Clark O H, Way L W, Hunt T K
Ann Surg. 1976 Oct;184(4):391-402. doi: 10.1097/00000658-197610000-00001.
Recurrent hyperparathyroidism occurred in 11 of 295 patients from 10 months to 34 years after an initially successful operation. Seven patients with recurrent hyperparathyroidism had either multiple endocrine adenomatosis type I (MEA) or familial hyperparathyroidism (FHP), one patient had parathyroid cancer, and two patients had renal failure at the time of recurrence. Four of these patients ahd their initial operations elsewhere. Recurrence developed in 33% of patients with MEA or FHP but in only 0.4% of 242 patients without MEA or FHP. The presence of MEA or FHP was known before parathyroid exploration in 18 (86%) of the 21 patients. In patients with MEA or FHP, subtotal parathyroidectomy should be performed if there is more than one gland involved. Other patients should be treated by selective removal of an adenoma because recurrence is rare. Subtotal parathyroidectomy should be reserved for patients with diffuse hyperplasia.
在最初手术成功后的10个月至34年里,295例患者中有11例发生复发性甲状旁腺功能亢进。7例复发性甲状旁腺功能亢进患者患有I型多发性内分泌腺瘤病(MEA)或家族性甲状旁腺功能亢进(FHP),1例患者患有甲状旁腺癌,2例患者在复发时患有肾衰竭。这些患者中有4例在其他地方接受了初次手术。MEA或FHP患者的复发率为33%,但在242例无MEA或FHP的患者中复发率仅为0.4%。21例患者中有18例(86%)在甲状旁腺探查前就已知道患有MEA或FHP。对于患有MEA或FHP且累及多个腺体的患者,应行甲状旁腺次全切除术。其他患者应通过选择性切除腺瘤进行治疗,因为复发很少见。甲状旁腺次全切除术应保留给弥漫性增生的患者。